Terns Pharmaceuticals【TERN】株式ニュース

名称	銘柄コード	市場	種別
Terns Pharmaceuticals Inc	TERN	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	-0.19	-2.61%	7.09	13:00:02

始値	安値	高値	終値	前日終値
7.11	7.06	7.5393	7.15	7.28

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/6/04	05:10	GLOBE	Terns Pharmaceuticals Reports Inducement Grants to New..
2024/5/30	21:05	GLOBE	Terns Pharmaceuticals to Participate in Upcoming June..
2024/5/18	05:05	GLOBE	Terns Pharmaceuticals to Participate in UBS Obesity..
2024/5/14	05:16	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/13	21:07	EDGAR2	Form 8-K - Current report
2024/5/13	21:05	GLOBE	Terns Pharmaceuticals Reports First Quarter 2024 Financial..
2024/5/09	05:05	GLOBE	Terns Pharmaceuticals Announces Leadership Changes
2024/5/08	05:05	GLOBE	Terns Pharmaceuticals to Participate in The Citizens JMP..
2024/5/04	05:05	GLOBE	Terns Pharmaceuticals Reports Inducement Grant to New..
2024/4/30	05:05	GLOBE	Terns Pharmaceuticals Announces Data from Ongoing Phase 1..
2024/4/11	05:05	GLOBE	Terns Pharmaceuticals Appoints Melita Sun Jung as Chief..
2024/3/15	05:05	GLOBE	Terns Pharmaceuticals Reports Fourth Quarter and Full Year..
2024/3/12	05:05	GLOBE	Terns Pharmaceuticals Announces Orphan Drug Designation..
2024/3/08	06:05	GLOBE	Terns Pharmaceuticals Reports Inducement Grant to New..
2024/3/06	08:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/28	06:05	GLOBE	Terns Pharmaceuticals to Participate in Upcoming March..
2024/2/16	08:02	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
2024/2/14	22:57	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/08	06:20	EDGAR2	Form 8-K - Current report
2024/2/08	06:05	GLOBE	Terns Pharmaceuticals Reports Inducement Grants to New Chief..
2024/2/07	22:05	GLOBE	Terns Pharmaceuticals Appoints Amy Burroughs as Chief..
2024/2/03	06:05	GLOBE	Terns Pharmaceuticals Reports Inducement Grant to New..
2024/1/26	09:17	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/05	06:05	GLOBE	Terns Pharmaceuticals to Highlight 2024 Priorities and..
2024/1/04	06:05	GLOBE	Terns Pharmaceuticals Reports Inducement Grant to New..
2023/11/30	06:05	GLOBE	Terns Pharmaceuticals to Present at the JMP Securities..
2023/11/28	06:05	GLOBE	Terns Pharmaceuticals Mourns the Loss of Senthil Sundaram,..
2023/11/14	22:05	GLOBE	Terns Pharmaceuticals Reports Third Quarter 2023 Financial..
2023/11/13	22:05	GLOBE	Terns Pharmaceuticals Presents Late-Breaking Data from Phase..
2023/11/09	22:05	GLOBE	Terns Pharmaceuticals to Participate in Upcoming November..
2023/11/04	05:05	GLOBE	Terns Pharmaceuticals Reports Inducement Grants to New..
2023/11/03	05:05	GLOBE	Terns Pharmaceuticals Announces First Participant Dosed in..
2023/10/20	05:05	GLOBE	Terns Pharmaceuticals to Participate in Upcoming Investor..
2023/10/16	21:05	GLOBE	Terns Pharmaceuticals Announces Global Phase 1 Clinical..
2023/10/11	05:33	EDGAR2	Form 8-K - Current report
2023/10/04	05:05	GLOBE	Terns Pharmaceuticals Reports Inducement Grants to New..
2023/9/07	05:05	GLOBE	Terns Pharmaceuticals Reports Inducement Grants to New..
2023/9/06	05:05	GLOBE	Terns Pharmaceuticals to Participate in Upcoming September..
2023/8/09	05:53	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/09	05:24	EDGAR2	Form 8-K - Current report
2023/8/09	05:15	GLOBE	Terns Pharmaceuticals Reports Second Quarter 2023 Financial..
2023/8/09	05:05	GLOBE	Terns Achieves Primary Endpoint and All Secondary Endpoints..
2023/8/04	07:00	GLOBE	Terns Pharmaceuticals Reports Inducement Grant to New..
2023/8/04	06:22	EDGAR2	Form 8-K - Current report
2023/8/04	06:05	GLOBE	Terns Pharmaceuticals Announces Leadership Transition
2023/7/19	05:05	GLOBE	Terns Pharmaceuticals to Host Virtual Key Opinion Leader..
2023/7/06	05:05	GLOBE	Terns Pharmaceuticals Reports Inducement Grants to New..
2023/6/27	05:05	GLOBE	Terns Pharmaceuticals Highlights New Preclinical Data for..